For children, young adults with recurrent AML, immunotherapy shows promise (Links to an external site)

Researchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that pre-activated natural killer cells can help some children and young adults with recurrent AML and few other treatment options. Pictured is Weston Robinett, 3, a patient who received this investigational therapy at Siteman Kids at St. Louis Children's Hospital and Washington University School of Medicine. He remains in remission more than two years after treatment.

An immunotherapy harnessing the immune system’s “natural killer” cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at Washington University School of Medicine in St. Louis have shown, in a small clinical trial, that the same natural killer cells also can help some children and young […]

Hunstad to study receptors in UTI (Links to an external site)

David Hunstad

David Alan Hunstad, MD, professor of pediatrics and of molecular microbiology at the School of Medicine, received a five-year $2 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) for research titled “Novel type 1 pilus receptors in pyelonephritis and recurrent UTI.”